文献速递糖尿病性腺与生殖内分泌

全基因组多基因风险评分可预测有妊娠糖尿病史的妇女发生2型糖尿病

Genome-Wide Polygenic Risk Score Predicts Incident Type 2 Diabetes in Women With History of Gestational Diabetes.
PubMed 文献 · Diabetes Care · 2024-01-01

研究利用五个独立队列共1895名有妊娠糖尿病史的妇女,评估全基因组2型糖尿病多基因风险评分与 incident 2型糖尿病风险的关联。中位随访2至30年间363人(19.2%)发生2型糖尿病,多基因风险评分与风险升高相关(每增加1个标准差 OR 1.52,95%CI 1.05-2.21,P=0.03)。将多基因风险评分加入临床模型后 AUROC 从0.71升至0.74,NRI 改善0.32(95%CI 0.15-0.49,P=3.0×10⁻⁴)。

要点

  • 有妊娠糖尿病史妇女中,2型糖尿病多基因风险评分与未来发生2型糖尿病风险升高相关(每1-SD OR 1.52)。
  • 将多基因风险评分加入年龄、家族史、收缩压和BMI模型后,AUROC由0.71升至0.74。
  • 多基因风险评分带来的预测改善幅度显著但较小,各队列趋势相似但存在变异。

核心结论

  • 在多种族妊娠糖尿病妇女队列中,2型糖尿病多基因风险评分与未来发生2型糖尿病显著相关,加入临床风险模型后AUROC有显著但小幅改善。

研究设计与样本

  • 研究使用代表四种不同祖先背景的五个独立队列,共纳入1895名有妊娠糖尿病史的妇女,分析全基因组2型糖尿病多基因风险评分与 incident 2型糖尿病的关联,并计算AUROC和连续NRI评估诊断效用。

主要发现

  • 1895名有妊娠糖尿病史妇女中,363名(19.2%)在2至30年间发生2型糖尿病。
  • 发生2型糖尿病者多基因风险评分高于未发生者(-0.08 vs 0.31,P=2.3×10⁻¹¹)。
  • 多基因风险评分与 incident 2型糖尿病风险升高相关(每增加1个标准差 OR 1.52,95%CI 1.05-2.21,P=0.03)。
  • 在包含年龄、糖尿病家族史、收缩压和BMI的模型中,加入多基因风险评分使2型糖尿病AUROC从0.71升至0.74,NRI改善0.32(95%CI 0.15-0.49,P=3.0×10⁻⁴)。
  • 各研究队列间存在变异,但观察到相似趋势。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Women with a history of gestational diabetes mellitus (GDM) are at increased risk of developing type 2 diabetes (T2D). It remains unclear whether genetic information improves prediction of incident T2D in these women. RESEARCH DESIGN AND METHODS: Using five independent cohorts representing four different ancestries (n = 1,895), we investigated whether a genome-wide T2D polygenic risk score (PRS) is associated with increased risk of incident T2D. We also calculated the area under the receiver operating characteristics curve (AUROC) and continuous net reclassification improvement (NRI) following the incorporation of T2D PRS into clinical risk models to assess the diagnostic utility. RESULTS: Among 1,895 women with previous history of GDM, 363 (19.2%) developed T2D in a range of 2 to 30 years. T2D PRS was higher in those who developed T2D (-0.08 vs. 0.31, P = 2.3 × 10-11) and was associated with an increased risk of incident T2D (odds ratio 1.52 per 1-SD increase, 95% CI 1.05-2.21, P = 0.03). In a model that includes age, family history of diabetes, systolic blood pressure, and BMI, the incorporation of PRS led to an increase in AUROC for T2D from 0.71 to 0.74 and an intermediate improvement of NRI (0.32, 95% CI 0.15-0.49, P = 3.0 × 10-4). Although there was variation, a similar trend was observed across study cohorts. CONCLUSIONS: In cohorts of GDM women with diverse ancestry, T2D PRS was significantly associated with future development of T2D. A significant but small improvement was observed in AUROC when T2D PRS was integrated into clinical risk models to predict incident T2D.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Choi J, Lee H, Kuang A, et al. Genome-Wide Polygenic Risk Score Predicts Incident Type 2 Diabetes in Women With History of Gestational Diabetes. Diabetes Care. 2024. PMID: 38940851. doi:10.2337/dc24-0022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。